Table 1.
Comparison of brachytherapy use as a component of treatment for the entire cohort
| EBRT | Brachy | p-value | Pair-wise comparison | |
|---|---|---|---|---|
| Race | < 0.001 | N/A | ||
| Caucasian (n = 33 425) | 56.4% | 43.6% | ||
| African American (n = 5279) | 60.9% | 39.1% | ||
| NCCN groups | < 0.001 | < 0.001 for all comparisons | ||
| Low (n = 15 213) | 43.9% | 56.1% | ||
| Intermediate (n = 15 678) | 61% | 39% | ||
| High (n = 7813) | 74.5% | 25.5% | ||
| Economic Status | < 0.001 | <0.001 unless otherwise noted | ||
| 1st (0-25%) quartile (n = 8815) | 68.5% | 31.5% | ||
| 2nd (25-50%) quartile (n = 9109) | 57.1% | 42.9% | ||
| 3rd (50-75%) quartile (n = 10 076) | 52.8% | 47.2% | 0.008 comparing quartile 3 and 4 | |
| 4th (75-100%) quartile (n = 10 703) | 51.3% | 48.7% |
EBRT – external beam radiation therapy, Brachy – brachytherapy, NCCN – National Cancer Care Network